Impact of stored red cells on clinical outcome in critically ill

Aaditya Shivhare, Shamee Shastry, Mohandoss Murugesan, Karishma Doshi, B. Baliga

Research output: Contribution to journalArticle

Abstract

Background: The use and benefit of fresh blood and leuco-reduced blood for critically ill patients has been inconclusive. In this study we have tried to observe the same, in patients admitted to intensive care unit. Study Design and Methods: Prospective study was done to observe the effect of transfusion in critically ill patients in a tertiary care hospital. Clinical condition in cases and controls was assessed with the help of Simplified Acute Physiology Score II scoring tool. Clinical outcome among patients who received blood was compared using two cutoffs, 14 and 21 days of shelf life to delineate fresh from old blood. Length of hospital stay, length of stay in ICU, number of days on ventilator and number of hospital acquired infections were used as the surrogate markers for morbidity. Results: Of the 558 critically ill patients admitted during the study period, 427 received (cases) while 131 did not receive the transfusion (controls). Mean SAPS II scores of cases and controls were comparable. We observed a significantly higher rate of mortality among patients who received RBC units over 21 days. However morbidity parameters were affected even when the cutoff of 14 days is considered. Buffy-coat reduced blood did not influence the outcome in the study group. Conclusion: Critically ill patients may be prioritized for receiving fresher units of packed red cells preferably less than 21 days old. Transfusion is an independent risk factor for morbidity. Hence the risk to benefit ratio should be carefully assessed for every red cell transfusion in critically ill patients.

Original languageEnglish
Pages (from-to)17-22
Number of pages6
JournalAsian Journal of Transfusion Science
Volume13
Issue number1
DOIs
Publication statusPublished - 01-01-2019

Fingerprint

Critical Illness
Length of Stay
Morbidity
Blood Buffy Coat
Tertiary Healthcare
Mechanical Ventilators
Cross Infection
Tertiary Care Centers
Intensive Care Units
Biomarkers
Outcome Assessment (Health Care)
Prospective Studies
Mortality

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Hematology

Cite this

Shivhare, Aaditya ; Shastry, Shamee ; Murugesan, Mohandoss ; Doshi, Karishma ; Baliga, B. / Impact of stored red cells on clinical outcome in critically ill. In: Asian Journal of Transfusion Science. 2019 ; Vol. 13, No. 1. pp. 17-22.
@article{0e215eb2601b411a9d98cc5499ab6b3b,
title = "Impact of stored red cells on clinical outcome in critically ill",
abstract = "Background: The use and benefit of fresh blood and leuco-reduced blood for critically ill patients has been inconclusive. In this study we have tried to observe the same, in patients admitted to intensive care unit. Study Design and Methods: Prospective study was done to observe the effect of transfusion in critically ill patients in a tertiary care hospital. Clinical condition in cases and controls was assessed with the help of Simplified Acute Physiology Score II scoring tool. Clinical outcome among patients who received blood was compared using two cutoffs, 14 and 21 days of shelf life to delineate fresh from old blood. Length of hospital stay, length of stay in ICU, number of days on ventilator and number of hospital acquired infections were used as the surrogate markers for morbidity. Results: Of the 558 critically ill patients admitted during the study period, 427 received (cases) while 131 did not receive the transfusion (controls). Mean SAPS II scores of cases and controls were comparable. We observed a significantly higher rate of mortality among patients who received RBC units over 21 days. However morbidity parameters were affected even when the cutoff of 14 days is considered. Buffy-coat reduced blood did not influence the outcome in the study group. Conclusion: Critically ill patients may be prioritized for receiving fresher units of packed red cells preferably less than 21 days old. Transfusion is an independent risk factor for morbidity. Hence the risk to benefit ratio should be carefully assessed for every red cell transfusion in critically ill patients.",
author = "Aaditya Shivhare and Shamee Shastry and Mohandoss Murugesan and Karishma Doshi and B. Baliga",
year = "2019",
month = "1",
day = "1",
doi = "10.4103/ajts.AJTS_76_18",
language = "English",
volume = "13",
pages = "17--22",
journal = "Asian Journal of Transfusion Science",
issn = "0973-6247",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

Impact of stored red cells on clinical outcome in critically ill. / Shivhare, Aaditya; Shastry, Shamee; Murugesan, Mohandoss; Doshi, Karishma; Baliga, B.

In: Asian Journal of Transfusion Science, Vol. 13, No. 1, 01.01.2019, p. 17-22.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Impact of stored red cells on clinical outcome in critically ill

AU - Shivhare, Aaditya

AU - Shastry, Shamee

AU - Murugesan, Mohandoss

AU - Doshi, Karishma

AU - Baliga, B.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: The use and benefit of fresh blood and leuco-reduced blood for critically ill patients has been inconclusive. In this study we have tried to observe the same, in patients admitted to intensive care unit. Study Design and Methods: Prospective study was done to observe the effect of transfusion in critically ill patients in a tertiary care hospital. Clinical condition in cases and controls was assessed with the help of Simplified Acute Physiology Score II scoring tool. Clinical outcome among patients who received blood was compared using two cutoffs, 14 and 21 days of shelf life to delineate fresh from old blood. Length of hospital stay, length of stay in ICU, number of days on ventilator and number of hospital acquired infections were used as the surrogate markers for morbidity. Results: Of the 558 critically ill patients admitted during the study period, 427 received (cases) while 131 did not receive the transfusion (controls). Mean SAPS II scores of cases and controls were comparable. We observed a significantly higher rate of mortality among patients who received RBC units over 21 days. However morbidity parameters were affected even when the cutoff of 14 days is considered. Buffy-coat reduced blood did not influence the outcome in the study group. Conclusion: Critically ill patients may be prioritized for receiving fresher units of packed red cells preferably less than 21 days old. Transfusion is an independent risk factor for morbidity. Hence the risk to benefit ratio should be carefully assessed for every red cell transfusion in critically ill patients.

AB - Background: The use and benefit of fresh blood and leuco-reduced blood for critically ill patients has been inconclusive. In this study we have tried to observe the same, in patients admitted to intensive care unit. Study Design and Methods: Prospective study was done to observe the effect of transfusion in critically ill patients in a tertiary care hospital. Clinical condition in cases and controls was assessed with the help of Simplified Acute Physiology Score II scoring tool. Clinical outcome among patients who received blood was compared using two cutoffs, 14 and 21 days of shelf life to delineate fresh from old blood. Length of hospital stay, length of stay in ICU, number of days on ventilator and number of hospital acquired infections were used as the surrogate markers for morbidity. Results: Of the 558 critically ill patients admitted during the study period, 427 received (cases) while 131 did not receive the transfusion (controls). Mean SAPS II scores of cases and controls were comparable. We observed a significantly higher rate of mortality among patients who received RBC units over 21 days. However morbidity parameters were affected even when the cutoff of 14 days is considered. Buffy-coat reduced blood did not influence the outcome in the study group. Conclusion: Critically ill patients may be prioritized for receiving fresher units of packed red cells preferably less than 21 days old. Transfusion is an independent risk factor for morbidity. Hence the risk to benefit ratio should be carefully assessed for every red cell transfusion in critically ill patients.

UR - http://www.scopus.com/inward/record.url?scp=85072074897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072074897&partnerID=8YFLogxK

U2 - 10.4103/ajts.AJTS_76_18

DO - 10.4103/ajts.AJTS_76_18

M3 - Article

VL - 13

SP - 17

EP - 22

JO - Asian Journal of Transfusion Science

JF - Asian Journal of Transfusion Science

SN - 0973-6247

IS - 1

ER -